Neuropeptide Y (NPY) is co-released with noradrenaline from sympathetic nerves, has a
strong vasoconstrictive action, and causes an attenuation of parasympathetic action in …

Publisher Summary This chapter focuses on the attempts to further characterize the
relationship of NPY to NE release under physiological and pathophysiological conditions …

Neuropeptide Y (NPY) is contained in and coreleased with norepinephrine (NE) from
sympathetic nerves innervating vascular and cardiac tissues. The effects of NPY infusion on …

The classical idea that cardiac performance is regulated by the two transmitter substances
noradrenaline and acetylcholine, derived from neurons of the sympathetic trunk and from the …

The direct and reflex-mediated components of the cardiovascular response to administration
of neuropeptide Y (NPY) in intact conscious rabbits were determined by studies with cardiac …

Neuropeptide Y (NPY) is a peptide with vasoconstrictor properties known to be present in
the central nervous system as well as in sympathetic nerve endings and the adrenal …

The actions of neuropeptide Y (NPY) on the circulation is currently the subject of much
research that has been stimulated by findings of its co-storage and cooperation with …

Neuropeptide Y (NPY) is coreleased with the classical transmitter noradrenaline in both the
peripheral and central nervous systems, and has been shown to potentiate the pressor …

Neuropeptide Y coexists with norepinephrine in sympathetic nerves and is coreleased into
the circulation on sympathetic activation. Little is known about the regional release of …

The sympathetic co-transmitter neuropeptide Y (NPY) inhibits cardiac contractility in vivo in
the rat heart. We tested whether NPY alters the force of contraction or the activity of …